202 related articles for article (PubMed ID: 37842518)
1. Honokiol inhibits the growth of hormone-resistant breast cancer cells: its promising effect in combination with metformin.
Mikhaevich EI; Sorokin DV; Scherbakov AM
Res Pharm Sci; 2023; 18(5):580-591. PubMed ID: 37842518
[TBL] [Abstract][Full Text] [Related]
2. Targeting hormone-resistant breast cancer cells with docetaxel: a look inside the resistance.
Scherbakov AM; Basharina AA; Sorokin DV; Mikhaevich EI; Mizaeva IE; Mikhaylova AL; Bogush TA; Krasil'nikov MA
Cancer Drug Resist; 2023; 6(1):103-115. PubMed ID: 37065867
[No Abstract] [Full Text] [Related]
3. Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway.
Yi X; Lou L; Wang J; Xiong J; Zhou S
Cancer Chemother Pharmacol; 2021 May; 87(5):647-656. PubMed ID: 33544209
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, Characterization and Biological Evaluation of Magnolol and Honokiol Derivatives with 1,3,5-Triazine of Metformin Cyclization.
Ren C; Wang J; Tan Y; Guo M; Guo J; Liu Y; Wu X; Feng Y
Molecules; 2020 Dec; 25(24):. PubMed ID: 33302335
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells.
Park EJ; Min HY; Chung HJ; Hong JY; Kang YJ; Hung TM; Youn UJ; Kim YS; Bae K; Kang SS; Lee SK
Cancer Lett; 2009 May; 277(2):133-40. PubMed ID: 19135778
[TBL] [Abstract][Full Text] [Related]
7. Flaxseed Lignans Enhance the Cytotoxicity of Chemotherapeutic Agents against Breast Cancer Cell Lines MDA-MB-231 and SKBR3.
Di Y; De Silva F; Krol ES; Alcorn J
Nutr Cancer; 2018; 70(2):306-315. PubMed ID: 29303360
[TBL] [Abstract][Full Text] [Related]
8. Honokiol synergizes chemotherapy drugs in multidrug resistant breast cancer cells via enhanced apoptosis and additional programmed necrotic death.
Tian W; Deng Y; Li L; He H; Sun J; Xu D
Int J Oncol; 2013 Feb; 42(2):721-32. PubMed ID: 23242346
[TBL] [Abstract][Full Text] [Related]
9. Overcoming Resistance to Cetuximab with Honokiol, A Small-Molecule Polyphenol.
Pearson HE; Iida M; Orbuch RA; McDaniel NK; Nickel KP; Kimple RJ; Arbiser JL; Wheeler DL
Mol Cancer Ther; 2018 Jan; 17(1):204-214. PubMed ID: 29054984
[TBL] [Abstract][Full Text] [Related]
10. Honokiol Inhibits DNA Polymerases β and λ and Increases Bleomycin Sensitivity of Human Cancer Cells.
Gowda AS; Suo Z; Spratt TE
Chem Res Toxicol; 2017 Feb; 30(2):715-725. PubMed ID: 28067485
[TBL] [Abstract][Full Text] [Related]
11. Natural Lignans Honokiol and Magnolol as Potential Anticarcinogenic and Anticancer Agents. A Comprehensive Mechanistic Review.
Mottaghi S; Abbaszadeh H
Nutr Cancer; 2022; 74(3):761-778. PubMed ID: 34047218
[TBL] [Abstract][Full Text] [Related]
12. Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction.
Hahm ER; Arlotti JA; Marynowski SW; Singh SV
Clin Cancer Res; 2008 Feb; 14(4):1248-57. PubMed ID: 18281560
[TBL] [Abstract][Full Text] [Related]
13. Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors.
Leeman-Neill RJ; Cai Q; Joyce SC; Thomas SM; Bhola NE; Neill DB; Arbiser JL; Grandis JR
Clin Cancer Res; 2010 May; 16(9):2571-9. PubMed ID: 20388852
[TBL] [Abstract][Full Text] [Related]
14. Honokiol suppresses survival signals mediated by Ras-dependent phospholipase D activity in human cancer cells.
Garcia A; Zheng Y; Zhao C; Toschi A; Fan J; Shraibman N; Brown HA; Bar-Sagi D; Foster DA; Arbiser JL
Clin Cancer Res; 2008 Jul; 14(13):4267-74. PubMed ID: 18594009
[TBL] [Abstract][Full Text] [Related]
15. The inhibitory effect of honokiol, a natural plant product, on vestibular schwannoma cells.
Lee JD; Lee JY; Baek BJ; Lee BD; Koh YW; Lee WS; Lee YJ; Kwon BM
Laryngoscope; 2012 Jan; 122(1):162-6. PubMed ID: 22057812
[TBL] [Abstract][Full Text] [Related]
16. Honokiol, a potential therapeutic agent, induces cell cycle arrest and program cell death in vitro and in vivo in human thyroid cancer cells.
Lu CH; Chen SH; Chang YS; Liu YW; Wu JY; Lim YP; Yu HI; Lee YR
Pharmacol Res; 2017 Jan; 115():288-298. PubMed ID: 27940017
[TBL] [Abstract][Full Text] [Related]
17. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
[TBL] [Abstract][Full Text] [Related]
18. Novel 1,3,4-thiadiazole/oxadiazole-linked honokiol derivatives suppress cancer via inducing PI3K/Akt/mTOR-dependent autophagy.
Xu T; Tian W; Zhang Q; Liu J; Liu Z; Jin J; Guo Y; Bai LP
Bioorg Chem; 2021 Oct; 115():105257. PubMed ID: 34426156
[TBL] [Abstract][Full Text] [Related]
19. Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
Tang H; Zhang Y; Li D; Fu S; Tang M; Wan L; Chen K; Liu Z; Xue L; Peng A; Ye H; Chen L
Eur J Med Chem; 2018 Aug; 156():190-205. PubMed ID: 30006164
[TBL] [Abstract][Full Text] [Related]
20. Honokiol enhances paclitaxel efficacy in multi-drug resistant human cancer model through the induction of apoptosis.
Wang X; Beitler JJ; Wang H; Lee MJ; Huang W; Koenig L; Nannapaneni S; Amin AR; Bonner M; Shin HJ; Chen ZG; Arbiser JL; Shin DM
PLoS One; 2014; 9(2):e86369. PubMed ID: 24586249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
